Skip to main content

Table 3 Mean BMD and BMC values of the affected and contralateral femoral neck and calcaneus for lower extremity sarcoma patients

From: Early decrements in bone density after completion of neoadjuvant chemotherapy in pediatric bone sarcoma patients

Scan region Affected
Mean (95% CI)
Contralateral
Mean (95% CI)
p-value*
FN (n = 29)    
aBMD (g/cm2) 0.877 (0.794 to 0.959) 0.993 (0.922 to 1.064) p < 0.001
vBMD (g/cm3) 0.358 (0.328 to 0.388) 0.402 (0.384 to 0.420) p < 0.001
BMC (g) 4.18 (3.66 to 4.69) 4.75 (4.22 to 5.28) p < 0.001
Calc (n = 25)    
aBMD (g/cm2) 0.457 (0.391 to 0.523) 0.583 (0.524 to 0.641) p < 0.001
BMC (g) 1.47 (1.26 to 1.68) 1.87 (1.69 to 2.06) p < 0.001
  1. BMD = bone mineral density, aBMD = areal bone mineral density (g/cm 2 ), vBMD = volumetric bone mineral density (g/cm 3 ), BMC = bone mineral content, CI = confidence interval, FN =femoral neck, Calc = calcaneus
  2. * Mann-Whitney U-test